AllMind

The AI-powered financial markets research terminal for institutional investors.

Stay Updated

H.C. Wainwright raises Relay Therapeutics price target to $29 | AllMind AI News

H.C. Wainwright raises Relay Therapeutics price target to $29

August 20, 2026

No financial news content was provided (only '403'), so themes, sentiment, and market impact cannot be assessed.

No financial news content was provided (only '403'), so themes, sentiment, and market impact cannot be assessed.

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Overall Sentiment

neutral

Sentiment Score

0.00

Wall Street Isn’t Buying Bessent Fix: Evening Briefing AmericasAugust 20, 2026
Applied Materials (AMAT) Q3 2026 Earnings Call TranscriptAugust 20, 2026
US pummels Cuban economy with new sanctions on mining, constructionAugust 20, 2026
Bessent's efforts in the Treasury market so far haven't worked. Here's what else he can tryAugust 20, 2026
Risk Of Treasuries Selloff Is Growing: RobsonAugust 20, 2026
Wall Street loves these high-yielding AI bonds. What income investors should knowAugust 20, 2026